We are live on
!
Find out more
GCM
Gladius Capital Management Portfolio holdings
AUM
$1.65B
1-Year Est. Return
25.75%
This Fund
S&P 500
This Quarter
Est. Return
-17.23%
1 Year Est. Return
+25.75%
3 Year Est. Return
+78.03%
5 Year Est. Return
+67.88%
10 Year Est. Return
+218.88%
AUM
$1.93B
AUM Growth
+$574M
(+42%)
Cap. Flow
+$864M
Cap. Flow
% of AUM
44.87%
Top 10 Holdings %
Top 10 Hldgs %
51.25%
Holding
447
New
182
Increased
81
Reduced
82
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$109M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$29.2M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$27.6M |
| 4 |
Netflix
NFLX
|
+$21.2M |
| 5 |
Caterpillar
CAT
|
+$20.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$40M |
| 2 |
Gilead Sciences
GILD
|
+$18.9M |
| 3 |
Tesla
TSLA
|
+$8.3M |
| 4 |
Wells Fargo
WFC
|
+$5.87M |
| 5 |
Visa
V
|
+$3.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.14% |
| 2 | Industrials | 2.22% |
| 3 | Communication Services | 1.34% |
| 4 | Financials | 1.2% |
| 5 | Consumer Staples | 1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Royalty Pharma
RPRX
$25.3B
| $40K | ﹤0.01% |
932
-2,737
| -75% | -$112K |
|
277
Bristow Group
VTOL
$1.35B
| $40K | ﹤0.01% |
+1,691
| New | +$49.8K |
|
|
SMMF
278
DELISTED
Summit Financial Group, Inc.
SMMF
| $40K | ﹤0.01% |
+1,439
| New | +$38.2K |
|
279
Cato Corp
CATO
$69.3M
| $39K | ﹤0.01% |
+3,341
| New | +$43.9K |
|
280
Lincoln National
LNC
$8.82B
| $39K | ﹤0.01% |
821
-837
| -50% | -$47.7K |
|
281
Matsons
MATX
$6.28B
| $39K | ﹤0.01% |
+534
| New | +$45.9K |
|
282
Alta Equipment Group
ALTG
$227M
| $38K | ﹤0.01% |
+4,160
| New | +$45.6K |
|
283
Genworth Financial
GNW
$3.76B
| $38K | ﹤0.01% |
+10,722
| New | +$41K |
|
284
Dave & Buster's
PLAY
$403M
| $38K | ﹤0.01% |
1,131
-1,047
| -48% | -$42K |
|
|
AKUS
285
DELISTED
Akouos Inc
AKUS
| $38K | ﹤0.01% |
+7,960
| New | +$28.1K |
|
286
Peabody Energy
BTU
$2.65B
| $36K | ﹤0.01% |
+1,670
| New | +$41K |
|
287
First Bank
FRBA
$471M
| $36K | ﹤0.01% |
+2,548
| New | +$36K |
|
288
Eli Lilly
LLY
$1,000B
| $36K | ﹤0.01% |
110
-176
| -62% | -$52.8K |
|
289
Amphastar Pharmaceuticals
AMPH
$892M
| $35K | ﹤0.01% |
+997
| New | +$35.6K |
|
|
DHIL
290
DELISTED
Diamond Hill
DHIL
| $35K | ﹤0.01% |
+198
| New | +$35.1K |
|
291
SPDR Gold Trust
GLD
$131B
| $34K | ﹤0.01% |
200
| – | – |
|
292
Carriage Services
CSV
$645M
| $33K | ﹤0.01% |
+826
| New | +$35.6K |
|
293
Jazz Pharmaceuticals
JAZZ
$15.8B
| $33K | ﹤0.01% |
+210
| New | +$32.3K |
|
|
LGF.A
294
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $33K | ﹤0.01% |
3,489
-518
| -13% | -$6.33K |
|
295
Corcept Therapeutics
CORT
$12.2B
| $31K | ﹤0.01% |
+1,288
| New | +$28.1K |
|
|
GORV
296
DELISTED
Lazydays
GORV
| $30K | ﹤0.01% |
+84
| New | +$42.7K |
|
297
IES Holdings
IESC
$14.4B
| $30K | ﹤0.01% |
+978
| New | +$31.5K |
|
298
Matrix Service
MTRX
$336M
| $29K | ﹤0.01% |
+5,658
| New | +$35.5K |
|
|
AGR
299
DELISTED
Avangrid, Inc.
AGR
| $29K | ﹤0.01% |
+615
| New | +$28.5K |
|
300
Erie Indemnity
ERIE
$12.4B
| $28K | ﹤0.01% |
143
-374
| -72% | -$65K |
|
Similar funds
ACM
CCM
BFPW
PP
RIA
GACM
GA
Gladius Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Gladius Capital Management held 447 positions worth $1.93B, up 42% from $1.35B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Gladius Capital Management deployed $864M of net new capital in Q2 2022, opening 182 new positions and adding to 81 existing holdings. Its largest new stake was Apple: 122,194 shares worth $16.7M.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 1.3% a quarter earlier, followed by Industrials and Communication Services.
On the sell side, the largest reduction was Gilead Sciences, an estimated $18.9M trimmed.
- Gladius Capital Management's largest Q2 2022 buy was Apple: 122,194 shares worth $16.7M.
- Gladius Capital Management added most to iShares MSCI EAFE ETF in Q2 2022, an estimated $109M increase.
- Gladius Capital Management's biggest Q2 2022 reduction was Gilead Sciences, cutting an estimated $18.9M.
- Gladius Capital Management fully exited Invesco QQQ Trust in Q2 2022, selling an estimated $40M.
- Gladius Capital Management's ten largest holdings make up 51% of its $1.93B portfolio in Q2 2022.
- Gladius Capital Management opened 182 new positions and closed 99 in Q2 2022.
- Gladius Capital Management's portfolio value rose 42% quarter-over-quarter to $1.93B.
Based on Gladius Capital Management's 13F filing for Q2 2022, filed 10 Aug 2022.